Stem Cells and Diabetes: A New Era of Regenerative Medicine

Diabetes is a chronic metabolic disorder and is recognized as the most common condition affecting the endocrine system. It is characterized by high blood sugar levels due to insulin resistance, insufficient insulin production, or a combination of both. This condition is often associated with various acute and chronic complications. Managing these complications has placed a considerable financial burden on many communities. Over the past decade, pancreatic islet transplantation has been thoroughly investigated as a potential treatment for diabetes. However, obtaining pancreatic cells from cadavers is quite difficult due to inherent limitations. Stem cells are being explored as a renewable cellular resource that could serve as an alternative to organ transplantation. These cells, found in nearly all multicellular organisms, have the unique ability to divide and differentiate into specialized cells, as well as to regenerate damaged or missing cells. The scientific community has extensively considered the potential application of stem cells in treating diabetes and developing insulin-producing islets, which may offer a promising future solution for diabetes management. Notably, human stem cells derived from hematopoietic organs, liver, pancreas, and embryonic sources are among the various types being studied. This article provides a brief overview of a series of research efforts conducted in this area.